ROCHE DRC PH 1 STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF RO7250284 FOLLOWING ITV ADMINISTRATION OF UNMASKED MULTIPLE ASCENDING DOSES AND MASKED SUSTAINED DELIVERY FROM THE PORT DELIVERY SYSTEM IN PATIENTS WITH NAMD
Research Grant
Administered By
Ophthalmology
Awarded By
Hoffman-La Roche, Inc.
Start Date
July 27, 2020
End Date
October 31, 2024
Administered By
Ophthalmology
Awarded By
Hoffman-La Roche, Inc.
Start Date
July 27, 2020
End Date
October 31, 2024